Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 26;187(26):7533-7550.e23.
doi: 10.1016/j.cell.2024.10.010. Epub 2024 Nov 4.

Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair

Affiliations

Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair

Kautilya K Jena et al. Cell. .

Abstract

Tissue damage and repair are hallmarks of inflammation. Despite a wealth of information on the mechanisms that govern tissue damage, mechanistic insight into how inflammation affects repair is lacking. Here, we investigated how interferons influence tissue repair after damage to the intestinal mucosa. We found that type III, not type I or type II, interferons delay epithelial cell regeneration by inducing the upregulation of Z-DNA-binding protein 1 (ZBP1). Z-nucleic acids formed following intestinal damage are sensed by ZBP1, leading to caspase-8 activation and the cleavage of gasdermin C (GSDMC). Cleaved GSDMC drives epithelial cell death by pyroptosis and delays repair of the large or small intestine after colitis or irradiation, respectively. The type III interferon/ZBP1/caspase-8/GSDMC axis is also active in patients with inflammatory bowel disease (IBD). Our findings highlight the capacity of type III interferons to delay gut repair, which has implications for IBD patients or individuals exposed to radiation therapies.

Keywords: Z-nucleic acid; colitis; damage; gasdermin; inflammation; inflammatory bowel disease; interferons; intestinal epithelial cell; intestinal stem cell; irradiation; pattern recognition receptors; pyroptosis; repair.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests I.Z., A.B., and S.B.S. have submitted a patent related to the matter of this paper.

References

    1. Meizlish ML, Franklin RA, Zhou X, and Medzhitov R (2021). Tissue Homeostasis and Inflammation. Annu Rev Immunol 39, 557–581. 10.1146/annurev-immunol-061020-053734. - DOI - PubMed
    1. Danese S, and Fiocchi C (2011). Ulcerative colitis. The New England journal of medicine 365, 1713–1725. 10.1056/NEJMra1102942. - DOI - PubMed
    1. Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, and Danese S (2020). Crohn’s disease. Nat Rev Dis Primers 6, 22. 10.1038/s41572-020-0156-2. - DOI - PubMed
    1. Villablanca EJ, Selin K, and Hedin CRH (2022). Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression? Nat Rev Gastroenterol Hepatol 19, 493–507. 10.1038/s41575-022-00604-y. - DOI - PubMed
    1. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, and Donnelly RP (2003). IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4, 69–77. 10.1038/ni875. - DOI - PubMed